Bioinspired agent kills drug-resistant bacteria

May 2, 2017, Frontiers
An antimicrobial treatment, inspired by enzymes in our immune system, can rapidly kill drug-resistant bacteria. Credit: Lilit Tonoyan, National University of Ireland Galway, Ireland

Researchers in Ireland have developed a bioinspired antimicrobial treatment that can rapidly kill drug-resistant bacteria. The treatment consists of iodo-thiocyanate complexes, which are inspired by enzymes and reactive molecules produced by our immune system.

Microbial resistance to antibiotics and biocides is increasing, and our ability to effectively treat bacterial infections and contamination is under threat. It is important that scientists develop new antibiotic drugs, but we also need new strategies to deal with that are not reliant on antibiotics.

"The rise of 'superbugs' leaves the clinical community with a rapidly dwindling number of options to treat infectious disease and to prevent the spread of resistant bacteria in, for example, hospital settings," explains Professor Vincent O'Flaherty of the National University of Ireland Galway, co-corresponding author on the study, recently published in Frontiers in Microbiology.

Hospital-acquired infections are a major concern for elderly or infirm patients. When the infection is antibiotic-resistant, serious illness or death can result. Bacterial contamination can occur on medical devices, such as catheters, which are embedded in patients. Bacteria tend to aggregate on these implants and form slimy layers called biofilms, and biofilms can also form on chronic wounds, impairing wound-healing. Biofilms are particularly resistant to decontamination strategies.

With this in mind, the researchers set out to develop an effective antibacterial treatment, drawing their inspiration from naturally-occurring peroxidase enzymes that play a role in immune defence against bacterial infections. Peroxidases can produce highly reactive oxidized molecules in the presence of hydrogen peroxide. Naturally present in bodily secretions such as saliva, milk and tears, these highly reactive substances can cause damage to bacterial cells, resulting in their death.

However, enzymes are expensive and impractical to produce in the quantities required for a widely useable antibacterial treatment. So, the researchers came up with an enzyme-free system consisting of and two oxidizable substances, iodide and thiocynate. These iodo-thiocyanate complexes produce highly reactive anti-microbial substances, without a peroxidase enzyme.

The team tested the complexes' ability to kill a variety of bacterial strains, including MRSA, an antibiotic-resistant strain. To do this, they treated the bacteria in cell suspensions, where the float freely, or in biofilms. They also tested if the bacteria became resistant to the complexes, by incubating them with small doses over time.

The complexes caused rapid bacterial death in all the tested strains, in some instances killing the bacteria within 30 seconds, even in small doses. They could kill both free-floating bacteria and those in biofilms, suggesting that they could be used for decontamination in a variety of situations. Finally, the complexes were also effective against MRSA, and the tested bacteria did not develop resistance over time.

Antibiotics often work by targeting one specific site in a bacterium. By including two oxidizable substances, the complexes produce a cocktail of antimicrobial molecules, damaging multiple bacterial sites simultaneously. This means that bacteria are unlikely to develop resistance to the complexes.

The team hope that the complexes could be applied as a disinfectant or even used to directly treat infected wounds. "We will need to assess the safety and suitability of the complexes for use in, or on, humans," says O'Flaherty. "We also need to develop delivery systems to deploy the treatment in a variety of settings that are currently affected by antibiotic-resistant ." The list of potential applications includes pre-surgery skin washes, disinfection of hospital surfaces and instruments, wound care, treatment of ulcers, and decontamination of medical devices.

Explore further: Tick protein helps antibiotics combat MRSA super bug

More information: Frontiers in Microbiology, DOI: 10.3389/fmicb.2017.00680 , http://journal.frontiersin.org/article/10.3389/fmicb.2017.00680/abstract

Related Stories

Tick protein helps antibiotics combat MRSA super bug

April 27, 2017

A protein derived from ticks enhances the effectiveness of antibiotic treatment for methicillin-resistant Staphylococcus aureus, or MRSA, according to a Yale-led study. The strategy of using the protein in combination with ...

Fighting MRSA with new membrane-busting compounds

March 15, 2017

Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA). The bacteria have developed resistance to a number of treatments, even antibiotics of last resort in some cases. ...

Researchers develop novel wound-healing technology

November 29, 2016

A WSU research team has successfully used a mild electric current to take on and beat drug-resistant bacterial infections, a technology that may eventually be used to treat chronic wound infections.

Strategies to decrease bacterial colonization

September 14, 2015

Among the bacterial infections that are most difficult to treat, chronic infections associated with bacterial biofilms are one of the most hazardous. Bacterial biofilms are densely packed communities of microbial cells surrounded ...

Recommended for you

How birds and insects reacted to the solar eclipse

November 14, 2018

A team of researchers with Cornell University and the University of Oxford has found that birds and insects reacted in some surprising ways to the 2017 U.S. total solar eclipse. In their paper published in the journal Biology ...

Symbiosis a driver of truffle diversity

November 14, 2018

While the sight of black or white truffle being shaved over on pasta is generally considered a sign of dining extravagance, they play an important role in soil ecosystem services. Truffles are the fruiting bodies of the ectomycorrhizal ...

Gene-edited food is coming, but will shoppers buy?

November 14, 2018

The next generation of biotech food is headed for the grocery aisles, and first up may be salad dressings or granola bars made with soybean oil genetically tweaked to be good for your heart.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.